| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | TCF4 TCF3 TCF7L2 HDAC4 EP400 NELFA GATA6 CHD8 CHD1 FANCM JMJD1C SBNO2 SETDB1 ATXN1 NFATC3 SNAI2 PKNOX1 TAF2 CRTC2 | 7.59e-08 | 739 | 119 | 19 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | TCF4 TEAD2 TCF3 TCF7L2 HDAC4 IRF2BP1 PCLO GATA3 GATA6 GCM1 JMJD1C FAF1 TBX18 GFI1B BRD8 NFATC3 CRTC2 | 2.35e-06 | 753 | 119 | 17 | GO:0008134 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.29e-04 | 320 | 119 | 9 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.48e-04 | 326 | 119 | 9 | GO:0001217 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TCF4 TCF3 TCF7L2 HDAC4 GATA3 GATA6 JMJD1C FAF1 TBX18 GFI1B BRD8 CRTC2 | 1.87e-04 | 582 | 119 | 12 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.99e-04 | 417 | 119 | 10 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TCF4 TEAD2 TCF3 TCF7L2 ARGFX TBX21 GATA3 GATA6 GCM1 TBX18 GFI1B AHRR KMT2D SALL2 NFATC3 YLPM1 SNAI2 PKNOX1 DLX4 HSF4 | 2.46e-04 | 1412 | 119 | 20 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TCF4 TEAD2 TCF3 TCF7L2 ARGFX HDAC4 TBX21 GATA3 GATA6 GCM1 TBX18 GFI1B SALL2 NFATC3 SNAI2 PKNOX1 DLX4 HSF4 | 4.05e-04 | 1244 | 119 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | E-box binding | 4.81e-04 | 61 | 119 | 4 | GO:0070888 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TCF4 TEAD2 TCF3 TCF7L2 ARGFX HDAC4 TBX21 GATA3 GATA6 GCM1 TBX18 GFI1B SALL2 NFATC3 SNAI2 PKNOX1 DLX4 HSF4 | 5.22e-04 | 1271 | 119 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | TCF4 TCF3 TCF7L2 TBX21 GATA3 GCM1 GFI1B KMT2D SALL2 NFATC3 HSF4 | 5.25e-04 | 560 | 119 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | TCF4 TCF3 TCF7L2 TBX21 GATA3 GCM1 GFI1B KMT2D SALL2 NFATC3 HSF4 | 5.73e-04 | 566 | 119 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.63e-04 | 120 | 119 | 5 | GO:0008013 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 1.23e-03 | 9 | 119 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.38e-03 | 37 | 119 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.29e-03 | 44 | 119 | 3 | GO:0140938 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TCF4 TCF3 TCF7L2 HDAC4 IRF2BP1 TBX21 GATA3 GATA6 CHD8 TENM2 HIPK3 TBX18 GFI1B SETDB1 AHRR SALL2 ATXN1 NFATC3 ATF7IP YLPM1 SNAI2 DLX4 HSF4 | 3.56e-08 | 1053 | 120 | 23 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TCF4 TCF3 TCF7L2 HDAC4 IRF2BP1 NELFA TBX21 GATA3 GATA6 CHD8 TENM2 SBNO2 HIPK3 TBX18 GFI1B SETDB1 AHRR SALL2 ATXN1 NFATC3 ATF7IP YLPM1 SNAI2 DLX4 HSF4 | 3.92e-07 | 1399 | 120 | 25 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TCF4 TCF3 TCF7L2 HDAC4 IRF2BP1 NELFA TBX21 GATA3 GATA6 CHD8 TENM2 SBNO2 HIPK3 TBX18 GFI1B SETDB1 AHRR SALL2 ATXN1 NFATC3 ATF7IP YLPM1 SNAI2 DLX4 HSF4 | 4.72e-07 | 1413 | 120 | 25 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TCF4 TEAD2 TCF3 TCF7L2 HDAC4 NELFA TBX21 GATA3 GATA6 GCM1 CHD8 SBNO2 GFI1B ABLIM1 BMPR2 KMT2D BRD8 SALL2 ATXN1 NFATC3 PKNOX1 TAF2 CRTC2 | 4.56e-06 | 1390 | 120 | 23 | GO:0045944 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TCF4 TCF3 HDAC4 EP400 GATA3 CHD8 CHD1 JMJD1C GFI1B SETDB1 SETD2 KMT2D BRD8 SLF2 ATF7IP SNAI2 TAF2 SPOCD1 | 1.87e-05 | 999 | 120 | 18 | GO:0071824 |
| GeneOntologyBiologicalProcess | chordate embryonic development | TEAD2 TCF7L2 GATA3 GATA6 GCM1 CHD8 TBX18 SETDB1 SETD2 BMPR2 HEG1 KMT2D SALL2 KIAA1217 DCHS1 CC2D2A RBM46 | 1.96e-05 | 906 | 120 | 17 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TEAD2 TCF7L2 GATA3 GATA6 GCM1 CHD8 TBX18 SETDB1 SETD2 BMPR2 HEG1 KMT2D SALL2 KIAA1217 DCHS1 CC2D2A RBM46 | 2.69e-05 | 929 | 120 | 17 | GO:0009792 |
| GeneOntologyBiologicalProcess | chromatin organization | TCF3 HDAC4 EP400 GATA3 CHD8 CHD1 JMJD1C GFI1B SETDB1 SETD2 KMT2D BRD8 SLF2 ATF7IP SNAI2 SPOCD1 | 6.34e-05 | 896 | 120 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | epithelium development | TEAD2 TCF7L2 CEACAM5 MAP1B OPN3 GATA3 GATA6 GCM1 HPSE JMJD1C TBX18 SETD2 BMPR2 HEG1 SALL2 NFATC3 TMEM132E SNAI2 DCHS1 CC2D2A HSF4 | 1.07e-04 | 1469 | 120 | 21 | GO:0060429 |
| GeneOntologyBiologicalProcess | heart development | TEAD2 SYNPO2L GATA3 GATA6 TBX18 SETD2 BMPR2 ADRA1B HEG1 NFATC3 SNAI2 DCHS1 CC2D2A PDLIM2 | 1.31e-04 | 757 | 120 | 14 | GO:0007507 |
| GeneOntologyCellularComponent | chromatin | TCF4 TEAD2 TCF3 TCF7L2 ARGFX HDAC4 EP400 TBX21 GATA3 GATA6 GCM1 CHD8 CHD1 FANCM JMJD1C TBX18 AHRR BRD8 NFATC3 SLF2 SNAI2 PKNOX1 DLX4 TAF2 HSF4 | 8.69e-07 | 1480 | 120 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | TCF4 TEAD2 TCF3 TCF7L2 HDAC4 GATA6 GCM1 TBX18 GFI1B NFATC3 ATF7IP PKNOX1 TAF2 | 3.88e-05 | 596 | 120 | 13 | GO:0005667 |
| GeneOntologyCellularComponent | beta-catenin-TCF7L2 complex | 9.77e-05 | 3 | 120 | 2 | GO:0070369 | |
| GeneOntologyCellularComponent | catenin-TCF7L2 complex | 1.95e-04 | 4 | 120 | 2 | GO:0071664 | |
| GeneOntologyCellularComponent | growth cone | 5.39e-04 | 245 | 120 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 6.52e-04 | 253 | 120 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | nuclear body | TCF7L2 AMER1 HDAC4 EP400 NELFA BARD1 TENM2 HIPK3 LIMK1 GARIN3 SLF2 ATF7IP YLPM1 HSF4 | 6.79e-04 | 903 | 120 | 14 | GO:0016604 |
| GeneOntologyCellularComponent | spine apparatus | 1.15e-03 | 9 | 120 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.46e-03 | 85 | 120 | 4 | GO:0000118 | |
| HumanPheno | Abnormal aortic valve morphology | AMER1 HDAC4 MAP1B GATA6 FANCM JMJD1C LIMK1 KMT2D DOCK7 TAF2 CAPN15 | 1.11e-05 | 289 | 41 | 11 | HP:0001646 |
| HumanPheno | Prominent fingertip pads | 2.83e-05 | 46 | 41 | 5 | HP:0001212 | |
| HumanPheno | Prominent digit pad | 3.49e-05 | 48 | 41 | 5 | HP:0011298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.59e-05 | 35 | 117 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 9.16e-05 | 38 | 117 | 4 | PS00690 | |
| Domain | Post-SET_dom | 1.26e-04 | 16 | 117 | 3 | IPR003616 | |
| Domain | PostSET | 1.26e-04 | 16 | 117 | 3 | SM00508 | |
| Domain | POST_SET | 1.26e-04 | 16 | 117 | 3 | PS50868 | |
| Domain | Tubby_C-like | 5.74e-04 | 6 | 117 | 2 | IPR025659 | |
| Domain | Tubby_C | 5.74e-04 | 6 | 117 | 2 | IPR000007 | |
| Domain | Liprin | 5.74e-04 | 6 | 117 | 2 | IPR029515 | |
| Domain | SNF2_N | 1.04e-03 | 32 | 117 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.04e-03 | 32 | 117 | 3 | PF00176 | |
| Domain | SET | 2.15e-03 | 41 | 117 | 3 | PF00856 | |
| Domain | ZnF_GATA | 2.46e-03 | 12 | 117 | 2 | SM00401 | |
| Domain | PDZ | 2.62e-03 | 151 | 117 | 5 | PS50106 | |
| Domain | PDZ | 2.70e-03 | 152 | 117 | 5 | IPR001478 | |
| Domain | SET | 2.99e-03 | 46 | 117 | 3 | SM00317 | |
| Domain | SET_dom | 3.79e-03 | 50 | 117 | 3 | IPR001214 | |
| Domain | SET | 3.79e-03 | 50 | 117 | 3 | PS50280 | |
| Domain | Znf_GATA | 3.87e-03 | 15 | 117 | 2 | IPR000679 | |
| Domain | GATA | 3.87e-03 | 15 | 117 | 2 | PF00320 | |
| Domain | GATA_ZN_FINGER_1 | 4.41e-03 | 16 | 117 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 4.41e-03 | 16 | 117 | 2 | PS50114 | |
| Domain | p53-like_TF_DNA-bd | 4.47e-03 | 53 | 117 | 3 | IPR008967 | |
| Domain | Helicase_C | 4.60e-03 | 107 | 117 | 4 | PF00271 | |
| Domain | HELICc | 4.60e-03 | 107 | 117 | 4 | SM00490 | |
| Domain | Helicase_C | 4.75e-03 | 108 | 117 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 4.91e-03 | 109 | 117 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.91e-03 | 109 | 117 | 4 | PS51192 | |
| Domain | DEXDc | 4.91e-03 | 109 | 117 | 4 | SM00487 | |
| Domain | Homeodomain-like | 4.93e-03 | 332 | 117 | 7 | IPR009057 | |
| Domain | TF_T-box | 4.98e-03 | 17 | 117 | 2 | IPR001699 | |
| Domain | HSP70_2 | 4.98e-03 | 17 | 117 | 2 | PS00329 | |
| Domain | HSP70_1 | 4.98e-03 | 17 | 117 | 2 | PS00297 | |
| Domain | TBOX | 4.98e-03 | 17 | 117 | 2 | SM00425 | |
| Domain | TF_T-box_CS | 4.98e-03 | 17 | 117 | 2 | IPR018186 | |
| Domain | - | 4.98e-03 | 17 | 117 | 2 | 2.60.40.820 | |
| Domain | TBOX_3 | 4.98e-03 | 17 | 117 | 2 | PS50252 | |
| Domain | T-box | 4.98e-03 | 17 | 117 | 2 | PF00907 | |
| Domain | HSP70_3 | 4.98e-03 | 17 | 117 | 2 | PS01036 | |
| Domain | TBOX_1 | 4.98e-03 | 17 | 117 | 2 | PS01283 | |
| Domain | TBOX_2 | 4.98e-03 | 17 | 117 | 2 | PS01264 | |
| Domain | Helicase_ATP-bd | 5.07e-03 | 110 | 117 | 4 | IPR014001 | |
| Domain | Hsp_70_fam | 5.58e-03 | 18 | 117 | 2 | IPR013126 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TCF4 TEAD2 TCF3 TCF7L2 ARGFX TBX21 GATA3 GATA6 GCM1 THAP4 TBX18 GFI1B KMT2D SALL2 NFATC3 SNAI2 PKNOX1 DLX4 HSF4 | 3.37e-10 | 908 | 120 | 19 | 19274049 |
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 8.25e-10 | 30 | 120 | 6 | 26593974 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES AMER1 HDAC4 MAP1B PPFIA1 DTL RUSC2 ABLIM1 LIMK1 VPS13D BMPR2 ATXN1 NFATC3 SLF2 KIAA1217 DOCK7 IRS2 CRTC2 | 1.05e-09 | 861 | 120 | 18 | 36931259 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TCF3 TCF7L2 AMER1 HDAC4 MAP1B BARD1 ADGRL1 SYNPO RBBP8NL NAALADL2 JMJD1C FAF1 SBNO2 FARP2 HIPK3 THAP4 ABLIM1 BMPR2 TULP4 ATXN1 KIAA1217 MAST1 FAM149A | 1.42e-09 | 1489 | 120 | 23 | 28611215 |
| Pubmed | KIF21B NES HDAC4 PRR36 KALRN PPFIA1 PKP4 CHD8 SYNPO PPFIA3 TENM2 ABLIM1 NFATC3 ATF7IP KIAA1217 YLPM1 DOCK7 DCHS1 | 5.99e-09 | 963 | 120 | 18 | 28671696 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | TCF4 TEAD2 ARGFX TBX21 GATA3 GATA6 GCM1 TBX18 GFI1B NFATC3 SNAI2 PKNOX1 DLX4 HSF4 | 6.53e-09 | 544 | 120 | 14 | 28473536 |
| Pubmed | EP400 RAP1GAP2 ADGRL1 TENM2 RUSC2 SETDB1 ABLIM1 SEMA6D GSE1 DOCK7 MAST1 ULK2 | 1.90e-08 | 407 | 120 | 12 | 12693553 | |
| Pubmed | TCF4 TEAD2 TCF3 TCF7L2 IRF2BP1 EP400 GATA3 GATA6 GCM1 CHD8 JMJD1C SETDB1 KMT2D BRD8 SALL2 GSE1 ATXN1 NFATC3 ATF7IP YLPM1 TAF2 | 1.92e-08 | 1429 | 120 | 21 | 35140242 | |
| Pubmed | Growth factor independent 1B (Gfi1b) is an E2A target gene that modulates Gata3 in T-cell lymphomas. | 4.01e-08 | 3 | 120 | 3 | 17272506 | |
| Pubmed | 6.87e-08 | 102 | 120 | 7 | 19741146 | ||
| Pubmed | TCF4 TEAD2 TCF3 TCF7L2 TBX21 GATA3 GATA6 ABLIM1 LIMK1 AHRR SALL2 SNAI2 PKNOX1 DLX4 | 1.73e-07 | 709 | 120 | 14 | 22988430 | |
| Pubmed | Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. | 2.38e-07 | 16 | 120 | 4 | 30886049 | |
| Pubmed | PPFIA1 CHD8 RBBP8NL JMJD1C SETDB1 KMT2D SALL2 GSE1 ATF7IP DOCK7 IRS2 | 2.38e-07 | 418 | 120 | 11 | 34709266 | |
| Pubmed | 4.16e-07 | 268 | 120 | 9 | 33640491 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.19e-07 | 351 | 120 | 10 | 38297188 | |
| Pubmed | 7.95e-07 | 6 | 120 | 3 | 18799618 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TCF4 TEAD2 TCF3 HDAC4 IRF2BP1 NELFA TBX21 GATA3 GATA6 BARD1 TBX18 NFATC3 PKNOX1 DLX4 | 2.14e-06 | 877 | 120 | 14 | 20211142 |
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 2.22e-06 | 8 | 120 | 3 | 32179550 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TCF4 TCF3 HDAC4 PKP4 KIF24 JMJD1C FAF1 HIPK3 VPS13D KIAA1217 PKNOX1 | 2.69e-06 | 536 | 120 | 11 | 15840001 |
| Pubmed | TCF4 TCF3 HDAC4 PKP4 KIF24 JMJD1C FAF1 HIPK3 VPS13D KIAA1217 PKNOX1 | 2.79e-06 | 538 | 120 | 11 | 10512203 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 3.22e-06 | 180 | 120 | 7 | 35198878 | |
| Pubmed | EP400 MAP1B CHD8 JMJD1C ABLIM1 SETD2 KMT2D BRD8 YLPM1 DOCK7 TAF2 | 3.38e-06 | 549 | 120 | 11 | 38280479 | |
| Pubmed | 3.50e-06 | 347 | 120 | 9 | 17114649 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | TEAD2 TCF7L2 HDAC4 IRF2BP1 JMJD1C KMT2D GSE1 YLPM1 DTX2 CRTC2 | 4.46e-06 | 457 | 120 | 10 | 32344865 |
| Pubmed | 4.72e-06 | 10 | 120 | 3 | 21828274 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TEAD2 EP400 KALRN RAP1GAP2 ADGRL1 CHD8 SBNO2 HEG1 KMT2D NUAK1 TULP4 IRS2 DTX2 ULK2 PRRT4 | 6.50e-06 | 1105 | 120 | 15 | 35748872 |
| Pubmed | EP400 PPFIA1 PKP4 CHD8 PPFIA3 SETDB1 SETD2 BRD8 SALL2 GSE1 ATXN1 RTL9 IRS2 TAF2 PDLIM2 | 7.31e-06 | 1116 | 120 | 15 | 31753913 | |
| Pubmed | HDAC4 RAP1GAP2 ADGRL1 CHD8 SYNPO HIPK3 SETDB1 ABLIM1 ATXN1 ATF7IP | 7.63e-06 | 486 | 120 | 10 | 20936779 | |
| Pubmed | 9.09e-06 | 38 | 120 | 4 | 28680062 | ||
| Pubmed | 1.05e-05 | 83 | 120 | 5 | 28794006 | ||
| Pubmed | Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. | 1.12e-05 | 13 | 120 | 3 | 19718027 | |
| Pubmed | Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. | 1.18e-05 | 2 | 120 | 2 | 15538389 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 35438764 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24680660 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 18619618 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 30682148 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 19861286 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20333526 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 34801967 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23413906 | ||
| Pubmed | Effect of ADSCs on Th17/Treg and T-bet/GATA-3 in model mice with primary immune thrombocytopenia. | 1.18e-05 | 2 | 120 | 2 | 38814224 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 15632006 | ||
| Pubmed | Circulating leukocyte TBET and GATA3 mRNA in patients with acute coronary syndrome. | 1.18e-05 | 2 | 120 | 2 | 22336257 | |
| Pubmed | T-bet, but not Gata3, overexpression is detrimental in a neurotropic viral infection. | 1.18e-05 | 2 | 120 | 2 | 28874814 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 29486619 | ||
| Pubmed | BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer. | 1.18e-05 | 2 | 120 | 2 | 34201956 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21468546 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 18212358 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17445473 | ||
| Pubmed | TCF 4 tumor suppressor: a molecular target in the prognosis of sporadic colorectal cancer in humans. | 1.18e-05 | 2 | 120 | 2 | 32265994 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23308012 | ||
| Pubmed | Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. | 1.18e-05 | 2 | 120 | 2 | 2105528 | |
| Pubmed | Predominance of intraglomerular T-bet or GATA3 may determine mechanism of transplant rejection. | 1.18e-05 | 2 | 120 | 2 | 21289214 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16520391 | ||
| Pubmed | E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment. | 1.18e-05 | 2 | 120 | 2 | 23297135 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12960249 | ||
| Pubmed | Research on the roles of transcription factors T-bet and GATA-3 in aplastic anemia. | 1.18e-05 | 2 | 120 | 2 | 24660543 | |
| Pubmed | Characterization of the Enzymatic Activity of SETDB1 and Its 1:1 Complex with ATF7IP. | 1.18e-05 | 2 | 120 | 2 | 26813693 | |
| Pubmed | Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer. | 1.18e-05 | 2 | 120 | 2 | 30614797 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 17074191 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24766459 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 34580284 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 30457553 | ||
| Pubmed | Two Hsp70 family members expressed in atherosclerotic lesions. | 1.18e-05 | 2 | 120 | 2 | 12552099 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24235972 | ||
| Pubmed | Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin. | 1.18e-05 | 2 | 120 | 2 | 22941175 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 16169686 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 19615257 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25575062 | ||
| Pubmed | Transcription factors T-bet and GATA-3 regulate development of airway remodeling. | 1.18e-05 | 2 | 120 | 2 | 16614350 | |
| Pubmed | Restraint of IFN-γ expression through a distal silencer CNS-28 for tissue homeostasis. | 1.18e-05 | 2 | 120 | 2 | 37040761 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 1.33e-05 | 410 | 120 | 9 | 26949251 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TCF3 AMER1 RAP1GAP2 RUSC2 FARP2 SETDB1 ABLIM1 SETD2 KIAA1217 MYPN DOCK7 IRS2 CRTC2 BORA | 1.45e-05 | 1038 | 120 | 14 | 26673895 |
| Pubmed | MAP1B PKP4 DGKA CHD8 JMJD1C SBNO2 RUSC2 FARP2 GSE1 DOCK7 CRTC2 | 1.65e-05 | 650 | 120 | 11 | 38777146 | |
| Pubmed | Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. | 2.17e-05 | 16 | 120 | 3 | 19487454 | |
| Pubmed | TCF4 TEAD2 TCF7L2 GATA3 GATA6 THAP4 GFI1B ABLIM1 LIMK1 BRD8 ATXN1 PKNOX1 | 2.43e-05 | 808 | 120 | 12 | 20412781 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.49e-05 | 444 | 120 | 9 | 34795231 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.55e-05 | 341 | 120 | 8 | 32971831 | |
| Pubmed | 2.58e-05 | 446 | 120 | 9 | 24255178 | ||
| Pubmed | 3.09e-05 | 255 | 120 | 7 | 15324660 | ||
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 3.46e-05 | 53 | 120 | 4 | 15572359 | |
| Pubmed | Lck mediates Th2 differentiation through effects on T-bet and GATA-3. | 3.53e-05 | 3 | 120 | 2 | 20237292 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 28465421 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 19295128 | ||
| Pubmed | Role of the IL-23-T-bet/GATA3 Axis for the Pathogenesis of Ulcerative Colitis. | 3.53e-05 | 3 | 120 | 2 | 33040251 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 26156402 | ||
| Pubmed | Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study. | 3.53e-05 | 3 | 120 | 2 | 21792548 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 17018611 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 24338248 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 27237631 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 15578569 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 19924301 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 30452683 | ||
| Pubmed | CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicing. | 3.53e-05 | 3 | 120 | 2 | 36537238 | |
| Pubmed | Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3. | 3.53e-05 | 3 | 120 | 2 | 29088218 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 9582372 | ||
| Pubmed | E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions. | 3.53e-05 | 3 | 120 | 2 | 17082585 | |
| Pubmed | Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9. | 3.53e-05 | 3 | 120 | 2 | 17852813 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 23469079 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 19155483 | ||
| Interaction | TLE3 interactions | TCF4 TCF3 TCF7L2 GATA3 GCM1 GFI1B SETD2 KMT2D BRD8 GSE1 ATXN1 CRTC2 | 2.36e-06 | 376 | 119 | 12 | int:TLE3 |
| Interaction | CREBBP interactions | TCF3 TCF7L2 ARGFX MAP1B TBX21 GATA3 GCM1 FAF1 HIPK3 GFI1B SETDB1 KMT2D ATXN1 ATF7IP SNAI2 | 2.50e-06 | 599 | 119 | 15 | int:CREBBP |
| Interaction | KDM1A interactions | TCF4 TCF3 EP400 PPFIA1 GATA3 CHD8 RBBP8NL JMJD1C GFI1B SETDB1 KMT2D SALL2 GSE1 ATXN1 ATF7IP KIAA1217 SNAI2 DOCK7 IRS2 | 2.56e-06 | 941 | 119 | 19 | int:KDM1A |
| Interaction | CTBP1 interactions | TCF4 TCF3 TCF7L2 HDAC4 EP400 PCLO GFI1B LIMK1 BMPR2 ATXN1 SNAI2 DTX2 | 5.18e-06 | 406 | 119 | 12 | int:CTBP1 |
| Interaction | HNF4A interactions | TCF7L2 HDAC4 IRF2BP1 EP400 SETDB1 KMT2D BRD8 GSE1 ATXN1 ATF7IP | 5.47e-06 | 275 | 119 | 10 | int:HNF4A |
| Interaction | YWHAH interactions | KIF21B NES AMER1 HDAC4 PPFIA1 DTL FAF1 RUSC2 ABLIM1 VPS13D NUAK1 ATXN1 NFATC3 SLF2 KIAA1217 DOCK7 MAST1 CC2D2A IRS2 CRTC2 | 6.73e-06 | 1102 | 119 | 20 | int:YWHAH |
| Interaction | ELK3 interactions | 7.19e-06 | 120 | 119 | 7 | int:ELK3 | |
| Interaction | NUP43 interactions | ARGFX EP400 CHD8 CHD1 JMJD1C SETD2 KMT2D BRD8 SALL2 GSE1 SLF2 ATF7IP AURKAIP1 TAF2 | 1.94e-05 | 625 | 119 | 14 | int:NUP43 |
| Interaction | GOLGA2 interactions | NES HDAC4 PKP4 SYNPO2L BARD1 JMJD1C RUSC2 ABLIM1 KMT2D SALL2 GSE1 KIAA1217 PRKAB2 CCDC87 DTX2 | 2.76e-05 | 733 | 119 | 15 | int:GOLGA2 |
| Interaction | GSE1 interactions | 3.64e-05 | 154 | 119 | 7 | int:GSE1 | |
| Interaction | GCM1 interactions | 5.11e-05 | 68 | 119 | 5 | int:GCM1 | |
| Interaction | BRPF3 interactions | 5.86e-05 | 166 | 119 | 7 | int:BRPF3 | |
| Interaction | ELF4 interactions | 6.22e-05 | 115 | 119 | 6 | int:ELF4 | |
| Interaction | KLF3 interactions | 6.34e-05 | 228 | 119 | 8 | int:KLF3 | |
| Interaction | ZSWIM8 interactions | 7.68e-05 | 74 | 119 | 5 | int:ZSWIM8 | |
| Interaction | BCOR interactions | 7.74e-05 | 302 | 119 | 9 | int:BCOR | |
| Interaction | ACTMAP interactions | 8.19e-05 | 75 | 119 | 5 | int:ACTMAP | |
| Interaction | CBFA2T3 interactions | 9.87e-05 | 78 | 119 | 5 | int:CBFA2T3 | |
| Interaction | FERD3L interactions | 1.06e-04 | 16 | 119 | 3 | int:FERD3L | |
| Interaction | FHL2 interactions | AMER1 EP400 KPRP ABLIM1 BMPR2 ATXN1 KIAA1217 PKNOX1 DTX2 BORA | 1.22e-04 | 396 | 119 | 10 | int:FHL2 |
| Interaction | NFIA interactions | 1.28e-04 | 188 | 119 | 7 | int:NFIA | |
| Interaction | FIGLA interactions | 1.29e-04 | 17 | 119 | 3 | int:FIGLA | |
| Interaction | UBE2I interactions | TCF4 TCF3 TCF7L2 HDAC4 DTL GCM1 FANCM FAF1 HIPK3 SETDB1 ATXN1 ATF7IP SNAI2 | 1.31e-04 | 654 | 119 | 13 | int:UBE2I |
| Interaction | MYOD1 interactions | 1.55e-04 | 194 | 119 | 7 | int:MYOD1 | |
| Interaction | NCK2 interactions | 1.66e-04 | 262 | 119 | 8 | int:NCK2 | |
| Interaction | RCOR1 interactions | TCF4 TCF3 PPFIA1 GATA3 CHD8 JMJD1C GFI1B KMT2D SALL2 GSE1 DOCK7 | 1.67e-04 | 494 | 119 | 11 | int:RCOR1 |
| Interaction | NEUROG1 interactions | 1.82e-04 | 19 | 119 | 3 | int:NEUROG1 | |
| Interaction | NFIB interactions | 1.99e-04 | 142 | 119 | 6 | int:NFIB | |
| Interaction | WWTR1 interactions | 2.04e-04 | 422 | 119 | 10 | int:WWTR1 | |
| Interaction | FEV interactions | 2.05e-04 | 203 | 119 | 7 | int:FEV | |
| Interaction | FOXI1 interactions | 2.15e-04 | 92 | 119 | 5 | int:FOXI1 | |
| Interaction | NHLRC4 interactions | 2.47e-04 | 21 | 119 | 3 | int:NHLRC4 | |
| Interaction | MYF6 interactions | 2.47e-04 | 21 | 119 | 3 | int:MYF6 | |
| Interaction | RTL9 interactions | 2.47e-04 | 21 | 119 | 3 | int:RTL9 | |
| Interaction | NFIC interactions | 2.52e-04 | 210 | 119 | 7 | int:NFIC | |
| Interaction | YWHAZ interactions | HDAC4 NELFA PPFIA1 DTL RAP1GAP2 BARD1 SYNPO PPFIA3 FAF1 RUSC2 ABLIM1 LIMK1 VPS13D ATXN1 NFATC3 DOCK7 MAST1 IRS2 CRTC2 | 2.59e-04 | 1319 | 119 | 19 | int:YWHAZ |
| Interaction | KALRN interactions | 2.63e-04 | 96 | 119 | 5 | int:KALRN | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.20e-04 | 34 | 78 | 3 | 487 | |
| GeneFamily | PDZ domain containing | 5.07e-04 | 152 | 78 | 5 | 1220 | |
| GeneFamily | Zinc fingers C2H2-type|SNAG transcriptional repressors | 8.09e-04 | 10 | 78 | 2 | 1259 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.86e-03 | 15 | 78 | 2 | 82 | |
| GeneFamily | LIM domain containing | 2.11e-03 | 59 | 78 | 3 | 1218 | |
| GeneFamily | Heat shock 70kDa proteins | 2.40e-03 | 17 | 78 | 2 | 583 | |
| GeneFamily | T-boxes | 2.69e-03 | 18 | 78 | 2 | 766 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 5.17e-03 | 25 | 78 | 2 | 775 | |
| Coexpression | SENESE_HDAC3_TARGETS_DN | TCF4 TCF3 PCLO PKP4 BARD1 ADGRL1 SYNPO TENM2 ABLIM1 HEG1 KMT2D NFATC3 DCHS1 PDLIM2 | 2.28e-07 | 548 | 120 | 14 | M16859 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TCF4 TCF7L2 MAP1B PPFIA1 DTL GATA6 FAF1 HIPK3 BRD8 NFATC3 ATF7IP PKNOX1 CA7 | 7.89e-07 | 519 | 120 | 13 | M3395 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TCF4 TCF7L2 MAP1B PPFIA1 DTL GATA6 FAF1 HIPK3 BRD8 NFATC3 ATF7IP PKNOX1 CA7 | 1.30e-06 | 543 | 120 | 13 | MM997 |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN | 4.04e-06 | 200 | 120 | 8 | M9588 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | KIF21B CELF5 MAP1B KALRN GATA3 RAP1GAP2 KLHL35 TENM2 GSE1 NUAK1 MAST1 | 9.96e-06 | 465 | 120 | 11 | M39066 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B CELF5 MAP1B PCLO GATA3 RAP1GAP2 ADGRL1 TENM2 RUSC2 HSPA12A SEMA6D GSE1 NUAK1 TULP4 PRKAB2 MAST1 PRRT4 | 1.19e-05 | 1106 | 120 | 17 | M39071 |
| Coexpression | GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP | 1.42e-05 | 171 | 120 | 7 | M6316 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_SCC_DN | 1.52e-05 | 115 | 120 | 6 | M7484 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML1 | 2.09e-05 | 328 | 120 | 9 | M39064 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 3.32e-05 | 195 | 120 | 7 | M1110 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 3.54e-05 | 197 | 120 | 7 | M5378 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP | 3.65e-05 | 198 | 120 | 7 | M5289 | |
| Coexpression | GSE3982_BCELL_VS_TH1_UP | 3.77e-05 | 199 | 120 | 7 | M5551 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN | 3.77e-05 | 199 | 120 | 7 | M9178 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TCF7L2 HDAC4 MAP1B PPFIA1 PKP4 BARD1 CHD1 SETDB1 SETD2 HEG1 GSE1 NUAK1 ATXN1 NFATC3 | 3.83e-05 | 856 | 120 | 14 | M4500 |
| Coexpression | GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 3.90e-05 | 200 | 120 | 7 | M293 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP | 3.90e-05 | 200 | 120 | 7 | M3407 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP | 4.84e-05 | 207 | 120 | 7 | MM475 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 6.46e-05 | 294 | 120 | 8 | M1804 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_DN | 8.41e-05 | 226 | 120 | 7 | M11238 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | KIF21B CELF5 TCF4 MAP1B PCLO RAP1GAP2 TENM2 ABLIM1 MAST1 IRS2 | 8.53e-05 | 488 | 120 | 10 | M39104 |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 9.37e-05 | 159 | 120 | 6 | M6502 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | KIF21B CELF5 MAP1B PCLO GATA3 RAP1GAP2 SEMA6D GSE1 NUAK1 TULP4 PKNOX1 MAST1 | 9.48e-05 | 703 | 120 | 12 | M39070 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | KIF21B CELF5 MAP1B RAP1GAP2 MUC16 KLHL35 SEMA6D GSE1 RTL9 MAST1 | 1.15e-04 | 506 | 120 | 10 | M39067 |
| Coexpression | XU_GH1_EXOGENOUS_TARGETS_UP | 1.28e-04 | 56 | 120 | 4 | M16128 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_DN | 1.35e-04 | 22 | 120 | 3 | MM793 | |
| Coexpression | SEKI_INFLAMMATORY_RESPONSE_LPS_DN | 1.55e-04 | 23 | 120 | 3 | M1980 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | 1.63e-04 | 429 | 120 | 9 | M45694 | |
| Coexpression | GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP | 1.68e-04 | 177 | 120 | 6 | M8177 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | TCF4 TCF3 CEACAM5 IRF2BP1 DGKA ADGRL1 CHD1 FANCM QSOX1 SETDB1 LIMK1 SEMA6D KIAA1217 | 1.82e-04 | 871 | 120 | 13 | MM1005 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.84e-04 | 180 | 120 | 6 | M8239 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | TCF4 TCF3 IRF2BP1 DGKA ADGRL1 CHD1 FANCM QSOX1 SETDB1 LIMK1 SEMA6D KIAA1217 | 2.66e-04 | 786 | 120 | 12 | M2388 |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP | 2.84e-04 | 195 | 120 | 6 | M4201 | |
| Coexpression | KIM_WT1_TARGETS_8HR_DN | 2.90e-04 | 126 | 120 | 5 | M9948 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 2.90e-04 | 126 | 120 | 5 | M9362 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.92e-04 | 196 | 120 | 6 | M4244 | |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP | 2.92e-04 | 196 | 120 | 6 | M7562 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 3.01e-04 | 466 | 120 | 9 | M13522 | |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN | 3.17e-04 | 199 | 120 | 6 | M5070 | |
| Coexpression | GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 3.17e-04 | 199 | 120 | 6 | M8388 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP | 3.25e-04 | 200 | 120 | 6 | M5979 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP | 3.25e-04 | 200 | 120 | 6 | M4588 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN | 3.25e-04 | 200 | 120 | 6 | M6634 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | 3.25e-04 | 200 | 120 | 6 | M7958 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN | 3.25e-04 | 200 | 120 | 6 | M6536 | |
| Coexpression | GSE24210_TCONV_VS_TREG_UP | 3.25e-04 | 200 | 120 | 6 | M7851 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 3.25e-04 | 200 | 120 | 6 | M6542 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_CULTURE_UP | 3.25e-04 | 200 | 120 | 6 | M7301 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 3.25e-04 | 200 | 120 | 6 | M8469 | |
| Coexpression | GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN | 3.25e-04 | 200 | 120 | 6 | M7157 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP | 3.25e-04 | 200 | 120 | 6 | M9840 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP | 3.25e-04 | 200 | 120 | 6 | M9294 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 3.25e-04 | 200 | 120 | 6 | M8869 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE | 3.47e-04 | 30 | 120 | 3 | M41011 | |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 3.48e-04 | 131 | 120 | 5 | M39232 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | KIF21B CELF5 MAP1B KALRN KLHL35 HSPA12A SEMA6D TULP4 MAST1 PRRT4 | 3.62e-04 | 584 | 120 | 10 | M39068 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 3.99e-04 | 135 | 120 | 5 | MM753 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 4.01e-04 | 208 | 120 | 6 | M39233 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 4.27e-04 | 137 | 120 | 5 | M39241 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 4.27e-04 | 137 | 120 | 5 | M4781 | |
| Coexpression | KREPPEL_CD99_TARGETS_DN | 4.30e-04 | 7 | 120 | 2 | M1269 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | TCF3 IRF2BP1 OPN3 DTL BARD1 FANCM KIF24 BRD8 YLPM1 MAST1 BORA | 4.48e-04 | 714 | 120 | 11 | M1744 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TCF4 TCF7L2 MAP1B KALRN PKP4 DGKA SYNPO ABLIM1 SEMA6D TULP4 YLPM1 DOCK7 ULK2 PDLIM2 | 5.25e-04 | 1102 | 120 | 14 | M2369 |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-08 | 185 | 120 | 8 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-08 | 188 | 120 | 8 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.70e-08 | 189 | 120 | 8 | d17e8467699c7ca7694a313c26111f085df5204e | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.75e-08 | 194 | 120 | 8 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-08 | 198 | 120 | 8 | f83956c4b13b5d0a0c6e3d9f580dbf99649ef175 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-08 | 198 | 120 | 8 | 5b86dc00acf8ac2ede008f5d79c09996485bf250 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-A_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.73e-08 | 198 | 120 | 8 | 5b5ccce5de82ea041465e656147cec3b8beb865b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-08 | 199 | 120 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-08 | 200 | 120 | 8 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|tumor_Lung / Location, Cell class and cell subclass | 5.30e-07 | 177 | 120 | 7 | f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5 | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-07 | 179 | 120 | 7 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.39e-07 | 182 | 120 | 7 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.39e-07 | 182 | 120 | 7 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.88e-07 | 184 | 120 | 7 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-07 | 186 | 120 | 7 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 7.67e-07 | 187 | 120 | 7 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-07 | 188 | 120 | 7 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-07 | 188 | 120 | 7 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-07 | 188 | 120 | 7 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 7.94e-07 | 188 | 120 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-07 | 188 | 120 | 7 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.94e-07 | 188 | 120 | 7 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Control-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 8.23e-07 | 189 | 120 | 7 | c76d8af2e0aa4a83ee0c3439c894566fbf117dd3 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 8.23e-07 | 189 | 120 | 7 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 8.53e-07 | 190 | 120 | 7 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.53e-07 | 190 | 120 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.53e-07 | 190 | 120 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.83e-07 | 191 | 120 | 7 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.83e-07 | 191 | 120 | 7 | 27a532a35d9e8822014f581fd56c4ca62e39f8fe | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.83e-07 | 191 | 120 | 7 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-07 | 191 | 120 | 7 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.83e-07 | 191 | 120 | 7 | 1dfcff08e01e6a695953334342bcfde04ba005ad | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 9.15e-07 | 192 | 120 | 7 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 193 | 120 | 7 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 193 | 120 | 7 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 193 | 120 | 7 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.80e-07 | 194 | 120 | 7 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.80e-07 | 194 | 120 | 7 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | Endothelial-A-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 9.80e-07 | 194 | 120 | 7 | e656ac5539e59e321b46706cb8cc423b2c3358a0 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-07 | 194 | 120 | 7 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-07 | 194 | 120 | 7 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 9.80e-07 | 194 | 120 | 7 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 196 | 120 | 7 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-06 | 197 | 120 | 7 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-06 | 197 | 120 | 7 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 198 | 120 | 7 | 5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-06 | 198 | 120 | 7 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-06 | 198 | 120 | 7 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.12e-06 | 198 | 120 | 7 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 198 | 120 | 7 | ff6d9455ebfe965cc6f48197172c0ebd3bddde81 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 198 | 120 | 7 | 5375a2895cf995f0db4a61861093f01794707901 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 198 | 120 | 7 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-06 | 198 | 120 | 7 | 13203249e5743ba2699871c184d141207e550a86 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.12e-06 | 198 | 120 | 7 | 35edf6d5bedc2181fbdd56f43e458bc39f4eca16 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-06 | 199 | 120 | 7 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | f35e9c05d0a0339ff691b38564da7aad8e9218aa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | Biopsy_IPF-Endothelial-Endothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 1.20e-06 | 200 | 120 | 7 | 39b4faad5700b3108f851f0df7fea3d298514465 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-06 | 200 | 120 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-06 | 200 | 120 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 200 | 120 | 7 | 93e13937ec74418a697c37d56f57509fb2154780 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 200 | 120 | 7 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.20e-06 | 200 | 120 | 7 | ec92fe4eafe527d351ee73c9735e96855ac506a3 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 200 | 120 | 7 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 1.20e-06 | 200 | 120 | 7 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-06 | 200 | 120 | 7 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.20e-06 | 200 | 120 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-06 | 140 | 120 | 6 | af9efcbaeeae69fcdac4a15fa244728b65915564 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 4.16e-06 | 156 | 120 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 5.74e-06 | 165 | 120 | 6 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-06 | 165 | 120 | 6 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-06 | 166 | 120 | 6 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-06 | 168 | 120 | 6 | 110c3c7c322e04a684a19c2b5434a502279fd000 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-06 | 168 | 120 | 6 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-06 | 168 | 120 | 6 | 735d30cfda1889740bdeb43e39330a52e8f4d599 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 7.53e-06 | 173 | 120 | 6 | 7e3897868dd3f6e4974f593c60649a543ffc8693 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-06 | 177 | 120 | 6 | fdf2af00fc971f0cd3915e1416e4a256458d6ea8 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-06 | 177 | 120 | 6 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.75e-06 | 181 | 120 | 6 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.75e-06 | 181 | 120 | 6 | 136b0c60680068838d184d32aa99d7bea8718dbc | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 182 | 120 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-05 | 182 | 120 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 184 | 120 | 6 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 1.07e-05 | 184 | 120 | 6 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-05 | 185 | 120 | 6 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.10e-05 | 185 | 120 | 6 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.10e-05 | 185 | 120 | 6 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.14e-05 | 186 | 120 | 6 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 1.14e-05 | 186 | 120 | 6 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-05 | 186 | 120 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 120 | 6 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 187 | 120 | 6 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HT_HG-U133A | 1.05e-07 | 199 | 120 | 10 | 1205_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; PC3; HG-U133A | 9.51e-07 | 195 | 120 | 9 | 1944_UP | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; PC3; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 6651_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A | 8.95e-06 | 194 | 120 | 8 | 6076_DN | |
| Drug | Securinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 9.29e-06 | 195 | 120 | 8 | 3470_DN | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 2783_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 9.64e-06 | 196 | 120 | 8 | 2108_DN | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 5819_DN | |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 2092_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.00e-05 | 197 | 120 | 8 | 5811_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 7557_DN | |
| Drug | Stachydrine hydrochloride; Down 200; 22.2uM; HL60; HG-U133A | 1.08e-05 | 199 | 120 | 8 | 1751_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HG-U133A | 1.12e-05 | 200 | 120 | 8 | 1943_UP | |
| Drug | monomethylarsonous acid | TCF3 HDAC4 PKP4 GATA6 GCM1 ADGRL1 HPSE RUSC2 TBX18 BMPR2 NFATC3 ATF7IP DCHS1 IRS2 | 1.78e-05 | 694 | 120 | 14 | ctd:C406082 |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 178 | 120 | 7 | 6220_UP | |
| Drug | 5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 4.65e-05 | 179 | 120 | 7 | 904_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 5.17e-05 | 182 | 120 | 7 | 1663_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 5.35e-05 | 183 | 120 | 7 | 7498_DN | |
| Drug | chrysene | CELF5 TCF7L2 TBX21 DTL DGKA MUC16 GCM1 PPFIA3 TENM2 ABLIM1 BMPR2 AHRR TULP4 SNAI2 PRRG3 | 5.47e-05 | 871 | 120 | 15 | ctd:C031180 |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 5.93e-05 | 186 | 120 | 7 | 6793_UP | |
| Drug | troglitazone; Down 200; 10uM; PC3; HT_HG-U133A | 6.56e-05 | 189 | 120 | 7 | 1232_DN | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 6.78e-05 | 190 | 120 | 7 | 2619_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 6.78e-05 | 190 | 120 | 7 | 7070_UP | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 7.01e-05 | 191 | 120 | 7 | 2048_DN | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.24e-05 | 192 | 120 | 7 | 849_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 7.48e-05 | 193 | 120 | 7 | 1363_DN | |
| Drug | Bromperidol [10457-90-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.73e-05 | 194 | 120 | 7 | 7457_DN | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 2770_UP | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 7413_DN | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 6918_UP | |
| Drug | Tolazamide [1156-19-0]; Up 200; 12.8uM; PC3; HT_HG-U133A | 7.98e-05 | 195 | 120 | 7 | 4003_UP | |
| Drug | ((1-ethylpyrrolidin-2-yl) methyl)-4-hydroxy-7-methoxy-quinoline-3-carboxamide | 8.24e-05 | 3 | 120 | 2 | ctd:C559381 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 3420_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 3066_DN | |
| Drug | indomethacin, USP; Up 200; 100uM; SKMEL5; HG-U133A | 8.24e-05 | 196 | 120 | 7 | 503_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; HL60; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 2531_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 8.24e-05 | 196 | 120 | 7 | 1078_UP | |
| Drug | Hecogenin [467-55-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.24e-05 | 196 | 120 | 7 | 7175_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 7431_DN | |
| Drug | LY294002; Down 200; 10uM; PC3; HG-U133A | 8.51e-05 | 197 | 120 | 7 | 429_DN | |
| Drug | Nicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; HL60; HG-U133A | 8.51e-05 | 197 | 120 | 7 | 1600_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 4077_UP | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2070_DN | |
| Drug | Colistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 4796_DN | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 5064_DN | |
| Drug | Tiaprofenic acid [33005-95-7]; Up 200; 15.4uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 2492_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 2080_DN | |
| Drug | HA-1077 dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 8.78e-05 | 198 | 120 | 7 | 343_UP | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 8.78e-05 | 198 | 120 | 7 | 166_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 3033_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 8.78e-05 | 198 | 120 | 7 | 996_UP | |
| Drug | Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 6080_DN | |
| Drug | Cefaclor [70356-03-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 2483_UP | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 7020_DN | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 2064_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 9.06e-05 | 199 | 120 | 7 | 408_DN | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 9.06e-05 | 199 | 120 | 7 | 3891_DN | |
| Drug | 5186223; Up 200; 12uM; MCF7; HT_HG-U133A_EA | 9.35e-05 | 200 | 120 | 7 | 885_UP | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; MCF7; HT_HG-U133A | 9.35e-05 | 200 | 120 | 7 | 1519_DN | |
| Drug | Amidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A | 9.35e-05 | 200 | 120 | 7 | 1376_DN | |
| Drug | Papulacandin D | 2.73e-04 | 5 | 120 | 2 | CID006442573 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.78e-04 | 169 | 120 | 6 | 6064_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.25e-04 | 174 | 120 | 6 | 7530_DN | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 3.56e-04 | 177 | 120 | 6 | 870_UP | |
| Drug | Parthenolide [20554-84-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.78e-04 | 179 | 120 | 6 | 5105_DN | |
| Drug | lomustine; Down 200; 100uM; PC3; HT_HG-U133A | 3.90e-04 | 180 | 120 | 6 | 7094_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 4.01e-04 | 181 | 120 | 6 | 1791_DN | |
| Drug | GW8510; Down 200; 10uM; PC3; HT_HG-U133A | 4.13e-04 | 182 | 120 | 6 | 7085_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 4.38e-04 | 184 | 120 | 6 | 4610_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A | 4.50e-04 | 185 | 120 | 6 | 5225_DN | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 4.64e-04 | 186 | 120 | 6 | 3819_DN | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 4.77e-04 | 187 | 120 | 6 | 5976_UP | |
| Drug | Nocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 4.90e-04 | 188 | 120 | 6 | 2239_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.90e-04 | 188 | 120 | 6 | 6735_DN | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 3788_DN | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.04e-04 | 189 | 120 | 6 | 836_UP | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 4716_DN | |
| Drug | C768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.04e-04 | 189 | 120 | 6 | 973_UP | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 5936_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 5.04e-04 | 189 | 120 | 6 | 5084_DN | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 5.19e-04 | 190 | 120 | 6 | 961_UP | |
| Drug | Azacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A | 5.19e-04 | 190 | 120 | 6 | 4010_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 6207_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 4450_DN | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 6162_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.48e-04 | 192 | 120 | 6 | 7427_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; HL60; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 3028_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 3908_DN | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 1236_DN | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 2690_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 6967_DN | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; HL60; HG-U133A | 5.63e-04 | 193 | 120 | 6 | 1988_UP | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 5.63e-04 | 193 | 120 | 6 | 7232_DN | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 7410_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 1223_DN | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 5448_DN | |
| Drug | Acetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 1707_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 6696_UP | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 4246_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 120 | 6 | 5454_DN | |
| Disease | mean reticulocyte volume | EP400 CHD1 JMJD1C FAF1 SBNO2 GFI1B ATF7IP KIAA1217 MAST1 CC2D2A IRS2 AURKAIP1 ATG4D BORA | 2.89e-06 | 799 | 115 | 14 | EFO_0010701 |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.24e-05 | 12 | 115 | 3 | C0023485 | |
| Disease | response to surgery | 1.51e-05 | 2 | 115 | 2 | EFO_0009951 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 4.51e-05 | 3 | 115 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | Drug habituation | 8.99e-05 | 115 | 115 | 5 | C0013170 | |
| Disease | Drug abuse | 8.99e-05 | 115 | 115 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 8.99e-05 | 115 | 115 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 8.99e-05 | 115 | 115 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 8.99e-05 | 115 | 115 | 5 | C0013222 | |
| Disease | Drug Dependence | 8.99e-05 | 115 | 115 | 5 | C1510472 | |
| Disease | Substance Dependence | 8.99e-05 | 115 | 115 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 8.99e-05 | 115 | 115 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.99e-05 | 115 | 115 | 5 | C0029231 | |
| Disease | Chromosome 2q37 deletion syndrome | 8.99e-05 | 4 | 115 | 2 | C2931817 | |
| Disease | Substance abuse problem | 9.36e-05 | 116 | 115 | 5 | C0740858 | |
| Disease | Malignant Cystosarcoma Phyllodes | 1.49e-04 | 5 | 115 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 1.49e-04 | 5 | 115 | 2 | C0010701 | |
| Disease | unipolar depression, irritable bowel syndrome | 1.76e-04 | 28 | 115 | 3 | EFO_0000555, EFO_0003761 | |
| Disease | household income | 1.95e-04 | 304 | 115 | 7 | EFO_0009695 | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 2.17e-04 | 30 | 115 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | retinopathy, type 2 diabetes mellitus | 2.24e-04 | 6 | 115 | 2 | EFO_0003839, MONDO_0005148 | |
| Disease | photoreceptor cell layer thickness measurement | 2.92e-04 | 148 | 115 | 5 | EFO_0803370 | |
| Disease | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 3.12e-04 | 7 | 115 | 2 | C3714844 | |
| Disease | Pulmonary Hypertension, Primary, 1 | 3.12e-04 | 7 | 115 | 2 | C4552070 | |
| Disease | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 3.12e-04 | 7 | 115 | 2 | C1969342 | |
| Disease | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 3.12e-04 | 7 | 115 | 2 | C1969343 | |
| Disease | docosahexaenoic acid measurement, sex interaction measurement | 3.12e-04 | 7 | 115 | 2 | EFO_0007761, EFO_0008343 | |
| Disease | risky sexual behaviour measurement | 5.37e-04 | 169 | 115 | 5 | EFO_0007877 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 5.74e-04 | 97 | 115 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | monocyte count | TCF4 TCF3 TCF7L2 KALRN RAP1GAP2 GFI1B SETD2 LIMK1 GSE1 ATXN1 YLPM1 MAST1 IRS2 RAPGEFL1 | 6.30e-04 | 1320 | 115 | 14 | EFO_0005091 |
| Disease | Fuchs endothelial corneal dystrophy | 6.64e-04 | 10 | 115 | 2 | Orphanet_98974 | |
| Disease | coffee consumption measurement, insomnia | 6.64e-04 | 10 | 115 | 2 | EFO_0004698, EFO_0006781 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 6.68e-04 | 101 | 115 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | sodium measurement | 7.19e-04 | 103 | 115 | 4 | EFO_0009282 | |
| Disease | immature platelet count | 8.01e-04 | 106 | 115 | 4 | EFO_0803544 | |
| Disease | Malignant mesothelioma | 8.89e-04 | 109 | 115 | 4 | C0345967 | |
| Disease | Malignant neoplasm of breast | HDAC4 KALRN GATA3 BARD1 HPSE SETD2 BMPR2 KMT2D SNAI2 SPOCD1 PLEKHA8 GABRA4 | 1.00e-03 | 1074 | 115 | 12 | C0006142 |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 1.05e-03 | 51 | 115 | 3 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.14e-03 | 200 | 115 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | immature platelet measurement | 1.23e-03 | 119 | 115 | 4 | EFO_0803541 | |
| Disease | mean corpuscular hemoglobin concentration | IRF2BP1 EP400 KALRN GFI1B BMPR2 ATXN1 KIAA1217 MAST1 CC2D2A IRS2 CAPN15 BORA | 1.28e-03 | 1105 | 115 | 12 | EFO_0004528 |
| Disease | colorectal cancer (is_implicated_in) | 1.31e-03 | 121 | 115 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | cognitive function measurement | TCF4 TCF7L2 KALRN NAALADL2 JMJD1C KMT2D SEMA6D TULP4 ATXN1 ATF7IP KIAA1217 MAST1 RBM46 TAF2 | 1.39e-03 | 1434 | 115 | 14 | EFO_0008354 |
| Disease | depressive symptom measurement | 1.43e-03 | 426 | 115 | 7 | EFO_0007006 | |
| Disease | platelet measurement | 1.50e-03 | 315 | 115 | 6 | EFO_0005036 | |
| Disease | Nephrosis | 1.53e-03 | 15 | 115 | 2 | C0027720 | |
| Disease | alcohol use disorder measurement | 1.54e-03 | 214 | 115 | 5 | EFO_0009458 | |
| Disease | Colorectal Carcinoma | 1.74e-03 | 702 | 115 | 9 | C0009402 | |
| Disease | cutaneous Leishmaniasis | 1.74e-03 | 16 | 115 | 2 | EFO_0005046 | |
| Disease | Idiopathic pulmonary arterial hypertension | 1.74e-03 | 16 | 115 | 2 | C3203102 | |
| Disease | body mass index, type 2 diabetes mellitus | 1.74e-03 | 16 | 115 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | irritable bowel syndrome | 1.75e-03 | 131 | 115 | 4 | EFO_0000555 | |
| Disease | Familial primary pulmonary hypertension | 1.97e-03 | 17 | 115 | 2 | C0340543 | |
| Disease | attention deficit hyperactivity disorder, schizophrenia | 2.02e-03 | 64 | 115 | 3 | EFO_0003888, MONDO_0005090 | |
| Disease | pulmonary hypertension (is_marker_for) | 2.02e-03 | 64 | 115 | 3 | DOID:6432 (is_marker_for) | |
| Disease | biological sex | 2.11e-03 | 230 | 115 | 5 | PATO_0000047 | |
| Disease | obsolete_red blood cell distribution width | IRF2BP1 EP400 KALRN GATA6 GFI1B BMPR2 AHRR KIAA1217 CTAGE1 YLPM1 MAST1 IRS2 BORA | 2.29e-03 | 1347 | 115 | 13 | EFO_0005192 |
| Disease | coffee consumption measurement, neuroticism measurement | 2.30e-03 | 67 | 115 | 3 | EFO_0006781, EFO_0007660 | |
| Disease | red blood cell density measurement | TCF7L2 EP400 KALRN PKP4 RBBP8NL JMJD1C FARP2 ADRA1B CC2D2A IRS2 | 2.36e-03 | 880 | 115 | 10 | EFO_0007978 |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 2.47e-03 | 19 | 115 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | cytomegalovirus virus reactivation, response to allogeneic hematopoietic stem cell transplant | 2.47e-03 | 19 | 115 | 2 | EFO_0007044, EFO_0020106 | |
| Disease | alopecia | 2.58e-03 | 241 | 115 | 5 | MONDO_0004907 | |
| Disease | corneal hysteresis | 2.73e-03 | 20 | 115 | 2 | EFO_0010066 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 2.87e-03 | 150 | 115 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | sleep duration | 3.00e-03 | 362 | 115 | 6 | EFO_0005271 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 3.01e-03 | 21 | 115 | 2 | C1292769 | |
| Disease | serum gamma-glutamyl transferase measurement | KALRN HSPA12B TENM2 JMJD1C FAF1 FARP2 SETD2 SEMA6D GSE1 NUAK1 | 3.09e-03 | 914 | 115 | 10 | EFO_0004532 |
| Disease | major depressive disorder | 3.22e-03 | 155 | 115 | 4 | MONDO_0002009 | |
| Disease | calcium measurement | 3.25e-03 | 628 | 115 | 8 | EFO_0004838 | |
| Disease | feeling "fed-up" measurement | 3.30e-03 | 76 | 115 | 3 | EFO_0009588 | |
| Disease | unipolar depression, bipolar disorder | 3.30e-03 | 156 | 115 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | balding measurement | 3.88e-03 | 792 | 115 | 9 | EFO_0007825 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPPRPDSLTGLRSSY | 376 | Q99569 | |
| PPSPSPSAYSSRTSR | 456 | A9YTQ3 | |
| RPYLSSPLRAPSEES | 1271 | Q96L91 | |
| LRAPGYPSSPVTTAS | 2511 | Q9HCK8 | |
| SPGTPPSTLSSSSYR | 391 | Q99728 | |
| TSEPSAYSPGGLVPR | 441 | A8MYA2 | |
| PSSETRASLYPPTLL | 496 | Q96RT6 | |
| SPRTLSPTPSAEGYQ | 426 | O14639 | |
| RSPIDSASPGGDYPL | 186 | Q9H0E9 | |
| TSRPLSSPPGRDSLY | 1371 | O94910 | |
| ASTPGSPLSPTEYER | 31 | Q8NEB7 | |
| GPDAPTISPLNTSYR | 236 | P06731 | |
| LLSTPYPFGLSPSSV | 176 | Q14687 | |
| YCSLNLPGSTDPPTS | 51 | A6NJG6 | |
| TSCRDLSSSPPGPYG | 176 | O43741 | |
| SRDSPLSLYTEPPGA | 941 | Q5JTC6 | |
| GSQRTLPSASPSPGY | 416 | P35368 | |
| SPYASESCGTLPLPL | 626 | Q9NZJ0 | |
| LSTGLDYSPPSAPRS | 81 | P54253 | |
| LPSYPVAPTSRASPS | 286 | Q9NVE4 | |
| SSSGPRSPLDQRSPY | 1671 | O14646 | |
| YPLGLSPTTAASPNL | 31 | Q92988 | |
| TPLPEPDLTRLYSGS | 561 | Q2TB18 | |
| LSSGTPSVLPYTSRP | 486 | Q8TBY0 | |
| PRSALYSPSDPLTLL | 31 | O00391 | |
| GDTVRYTPASPSSPD | 326 | O75808 | |
| LILSTTGYPFSSPEP | 256 | Q8WXI7 | |
| YRLAGTPPPGTTVDS | 2001 | Q96JQ0 | |
| REGSAAPLPLYTSPS | 336 | P56524 | |
| SPLRSPPLIGSESAY | 1396 | P46821 | |
| PLTPRESSPLYSPTF | 1786 | P46821 | |
| SYIPSSETPPAPSSR | 336 | Q9H3P2 | |
| APLLSSPYSRGSAAS | 71 | A5PLN7 | |
| PPSLGSQPLYRSSLS | 271 | Q86UW9 | |
| SLYGSPLVPSTEPAL | 136 | Q5VTD9 | |
| PPSSYSRSLPGSALE | 501 | O75145 | |
| RDSPGYPSSKPATST | 196 | P15884 | |
| EGSYSSLSPPTLTPV | 1221 | Q15652 | |
| ERFLSYSPPPLSGLS | 991 | Q8IYD8 | |
| PTEGYSPPAASTRAA | 16 | Q969W3 | |
| PSSRPSSVYGLDLSI | 4291 | Q9Y6V0 | |
| SSFLPTVSLPPGLEY | 46 | A0PG75 | |
| ARSPYSLGASPAAPA | 511 | O75037 | |
| RSYSPPLPSGLSSWS | 466 | Q86SU0 | |
| ASPRPYSSVPAGSEK | 2261 | O60229 | |
| PSSIYPSVLASGPDR | 331 | P23743 | |
| PDSTPLGFYLRSPTS | 1296 | P48681 | |
| SSGPSPRDSLAEKPY | 926 | Q5T7B8 | |
| SPSAPPTSRTTLAYG | 946 | Q13136 | |
| SKGTPRSYLASSPNP | 421 | P48169 | |
| EYSPASRSLGTSPSP | 936 | Q9ULI3 | |
| GPRETAPTSAYSSPA | 11 | O43301 | |
| AFTSELLYRTPPGSP | 176 | Q96JA3 | |
| GLYIGSSPERSPVPS | 11 | Q96MM6 | |
| PTLLPYPSSATLSSA | 1116 | Q9H422 | |
| LRPGSSLGLPAFSYS | 516 | Q9Y251 | |
| SSPSRDYSPAVSGLR | 951 | Q9Y2H9 | |
| GLPARSPTHSYRSTP | 1131 | Q9Y2H9 | |
| SLDGLLSPEASSPYP | 1001 | Q9Y4H2 | |
| SPAPLFSPGTYERLA | 31 | Q9H1Y3 | |
| SPPSPAYERGLSLDS | 251 | Q8NC74 | |
| VPEYSSGLFPPSSLL | 226 | P23771 | |
| AGPPARSLLLSSYAS | 71 | Q92908 | |
| FSRSLPYPGLSSVQP | 1466 | Q9P2K1 | |
| YTIASPPERSPSGSA | 1421 | Q96N67 | |
| TSSPVLGAPSYPAST | 406 | Q53ET0 | |
| YSLGSITSPSPISSP | 261 | Q6PGQ7 | |
| GILTPSLTLPFSPYS | 231 | Q8N6W0 | |
| SRTYSSGDLLPPSAS | 271 | Q9NP62 | |
| PDPLSSTSSSLLYPL | 696 | Q13873 | |
| SPSPLELAYVPSRST | 76 | A6NIL9 | |
| RTSLPTVGPSGLYSP | 886 | Q6VMQ6 | |
| TPGERSSLPAFYPGT | 21 | Q9UBK5 | |
| PESRTASYLGPEASP | 476 | Q9ULV5 | |
| EPCSSSYLPLRPSEG | 276 | Q5T749 | |
| YPGSLTTPPLSESVT | 196 | P43166 | |
| SLYVLTPDLPPPSSS | 166 | Q9UNN5 | |
| FYSLSPSTLVPSGLP | 406 | O94887 | |
| PYVLEPLGASPSETS | 576 | Q9Y467 | |
| TSSGRLPLPSPALEY | 116 | Q8IU81 | |
| SYCSTPTLLSGDAPP | 181 | Q8TC56 | |
| PRTSYSSLSSPGTSP | 931 | Q9P2F6 | |
| GSEPETSRPSPLGSY | 766 | Q8N2Y8 | |
| TSRPSPLGSYSPIRS | 771 | Q8N2Y8 | |
| PASGEIATPLRSPAY | 801 | Q8NET4 | |
| SGPVTATSSLYIPAP | 541 | Q9H987 | |
| VYSPSPSSESPSLGA | 676 | Q684P5 | |
| ILLYLAPNSSSPSSP | 311 | Q6IEE7 | |
| SETLLSGEPGSPYSP | 156 | P55347 | |
| ALPRPSRSSPGLYTS | 856 | Q8N3V7 | |
| ERPSTPGLSKYRPAS | 1066 | Q6P1X5 | |
| PSRSPSSTLSGPDLA | 1106 | Q9H6K5 | |
| LSGYSSSLGRVSPPP | 76 | O43623 | |
| PPRRSYLPGSGLTTT | 1051 | Q5T5P2 | |
| PPDITYTLALPSDSG | 231 | Q9Y2G9 | |
| STPLFSSSSPGYPLT | 326 | Q9NT68 | |
| VPAEGLSRSYSRPSS | 556 | O60285 | |
| TLSLTPPSTDLPGYE | 186 | Q15562 | |
| RSEYGTPTKSPPAAL | 546 | Q8IX21 | |
| SYSSPTSLSPRAGSP | 121 | Q96JY6 | |
| YRSPLGSTASAPAPS | 526 | Q15047 | |
| PLYSTSPAGPGRAAS | 36 | Q9NWT8 | |
| STSAPAISRGPSEYP | 201 | P56747 | |
| PPELSGSASPSRYHG | 176 | Q86TL0 | |
| SAETDTPLLPPYLSS | 1391 | Q9BXT8 | |
| PLASQSSYSLLSPPD | 1061 | Q9NRJ4 | |
| TLPDLSRPPDSYSGL | 471 | P15923 | |
| PPRTPSYVGVSSSTS | 451 | O95935 | |
| LSDPFYPPRSGSLAL | 551 | Q6ZMY3 | |
| YPPRSGSLALGDPSS | 556 | Q6ZMY3 | |
| LTSPYLPNGSLSPTA | 111 | Q9NQB0 | |
| LPLEPSYRESSLSPS | 151 | Q12968 | |
| LPASGSYQALSPPSR | 846 | C9JH25 | |
| LSPPSSAYERGTKRP | 2081 | Q9BYW2 | |
| YITPSTSLSPRQSGP | 821 | P49750 | |
| YLSSLSSSQPPEPLR | 56 | Q8NA96 | |
| RLSTGSSRPYSPSPL | 466 | Q8IYT8 | |
| YSSDELSPGEPLTSP | 126 | Q9UHV5 | |
| EASLYSPPSTLPRNS | 926 | Q8NFY4 | |
| SLSRLSSTTPPPSYE | 181 | Q9BZD7 | |
| SVPYPSSLLSPSREP | 401 | Q8WY91 | |
| RVSPYPSSGDSSSPA | 501 | Q9UL17 | |
| YPASATSSPCPDSPL | 1561 | Q5THJ4 | |
| PLPSLPGYTRSEFAA | 331 | Q6PF15 | |
| TGESYGLSPLRPPSV | 2601 | O14686 | |
| PPRSPERTLSPSSGY | 511 | Q9P206 | |
| LGPETSPLSSPAYTP | 266 | P53667 | |
| NYSVLLDLPGPSPST | 216 | Q58DX5 | |
| TPGSSPSSLYYEEPL | 251 | Q86TC9 |